Investor Paradigm Biocapital Advisors LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Paradigm Biocapital Advisors LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-28 13G AGIO / Agios Pharmaceuticals, Inc. 3,027,977
2025-08-14 13G/A JANX / Janux Therapeutics, Inc. 3,515,986 2,920,258
2025-08-14 13G/A COGT / Cogent Biosciences, Inc. 8,963,655 10,352,449
2025-08-12 13G URGN / UroGen Pharma Ltd. 2,332,066
2025-07-30 13G CDTX / Cidara Therapeutics, Inc. 1,128,613
2025-05-15 13G/A PLRX / Pliant Therapeutics, Inc. 3,059,411 0
2025-05-15 13G/A IRON / Disc Medicine, Inc. 1,497,720 1,210,971
2025-05-15 13G/A COGT / Cogent Biosciences, Inc. 5,559,924 8,963,655
2025-04-10 13G MRUS / Merus N.V. 3,554,059
2025-03-27 13G LENZ / LENZ Therapeutics, Inc. 1,419,832
2025-02-14 13G/A OLMA / Olema Pharmaceuticals, Inc. 5,503,600 7,429,355
2025-02-14 13G/A KURA / Kura Oncology, Inc. 4,331,321 0
2025-02-14 13G/A JANX / Janux Therapeutics, Inc. 2,608,574 3,515,986
2025-02-12 13G COGT / Cogent Biosciences, Inc. 5,559,924
2025-02-03 13G EWTX / Edgewise Therapeutics, Inc. 4,738,929
2024-11-14 13G/A NUVL / Nuvalent, Inc. 3,858,008 5,000,000
2024-11-14 13G/A OLMA / Olema Pharmaceuticals, Inc. 7,903,600 5,503,600
2024-11-14 13G/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 3,425,988 2,320,000
2024-11-14 13G/A ACLX / Arcellx, Inc. 3,658,624 4,800,000
2024-11-14 13G/A TARS / Tarsus Pharmaceuticals, Inc. 1,927,506 2,440,445
2024-11-14 13G/A KURA / Kura Oncology, Inc. 3,861,318 4,331,321
2024-11-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 12,611,335 0
2024-11-14 13G/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 3,707,001 0
2024-11-14 13G/A IRON / Disc Medicine, Inc. 2,385,857 1,497,720
2024-11-14 13G/A VRDN / Viridian Therapeutics, Inc. 5,304,313 3,509,253
2024-11-14 13G/A VOR / Vor Biopharma Inc. 6,457,293 0
2024-11-14 13G/A YMAB / Y-mAbs Therapeutics, Inc. 2,198,312 4,086,346
2024-10-23 13G JANX / Janux Therapeutics, Inc. 2,608,574
2024-10-04 13G PLRX / Pliant Therapeutics, Inc. 3,059,411
2024-05-02 13G KURA / Kura Oncology, Inc. 3,861,318
2024-04-08 13G YMAB / Y-mAbs Therapeutics, Inc. 2,198,312
2024-02-14 13G/A ACLX / Arcellx, Inc. 2,422,700 3,658,624
2024-02-14 13G/A AMAM / Ambrx Biopharma Inc. 4,502,689
2024-02-14 13G/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 10,098,584 12,611,335
2024-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 2,317,634 3,176,743
2024-02-14 13G/A IRON / Disc Medicine, Inc. 1,235,918 2,385,857
2024-02-14 13G/A BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,610,665 3,707,001
2024-02-14 13G/A OLMA / Olema Pharmaceuticals, Inc. 7,803,600 7,903,600
2024-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 2,310,698 5,304,313
2024-02-14 13G CRBP / Corbus Pharmaceuticals Holdings, Inc. 399,658 0
2024-02-14 13G/A VOR / Vor Biopharma Inc. 6,477,999 6,457,293
2024-02-14 13G/A CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 3,425,988
2024-02-14 13G/A NUVL / Nuvalent, Inc. 3,379,080 3,858,008
2024-02-05 13G CRBP / Corbus Pharmaceuticals Holdings, Inc. 399,658
2024-01-22 13G TARS / Tarsus Pharmaceuticals, Inc. 1,927,506
2024-01-02 13G CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock) 3,425,988
2023-10-30 13G NUVL / Nuvalent, Inc. 3,379,080
2023-09-25 13G AMAM / Ambrx Biopharma Inc. 25,172,784
2023-09-25 13G IRON / Disc Medicine, Inc. 1,235,918
2023-09-13 13G/A OLMA / Olema Pharmaceuticals, Inc. 2,515,111 7,803,600
2023-07-21 13G ACLX / Arcellx, Inc. 2,422,700
2023-07-10 13G AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) 10,098,584
2023-05-11 13G VRDN / Viridian Therapeutics, Inc. 1,891,167 2,310,698
2023-04-10 13G OLMA / Olema Pharmaceuticals, Inc. 2,515,111
2023-02-24 13G BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) 1,610,665
2023-02-14 13G/A OYST / Oyster Point Pharma Inc 1,462,576 0
2023-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 1,209,051 1,891,167
2023-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 2,214,722 2,317,634
2023-02-14 13G/A VOR / Vor Biopharma Inc. 2,328,494 6,477,999
2022-10-27 13G VOR / Vor Biopharma Inc. 2,328,494
2022-10-03 13G ALPN / Alpine Immune Sciences, Inc. 2,214,722
2022-07-18 13G OYST / Oyster Point Pharma Inc 1,462,576
2022-02-14 13G VRDN / Viridian Therapeutics, Inc. 1,209,051